|
AP7058a-ev
|
Abcepta, Inc.
|
MNK2 [MKNK2] [N-term] [RB5445], Rabbit Polyclonal Antibody
|
Human
|
WB
|
|
|
AP7058a
|
Abcepta, Inc.
|
MNK2 [MKNK2] [N-term] [RB5445], Rabbit Polyclonal Antibody
|
Human
|
WB
|
|
|
GTX20012
|
GeneTex International Corporation
|
HDAC1, Rabbit Polyclonal Antibody
|
Human, Mouse
|
ELISA, ICC/IF, IP, WB, ChIP assay
|
|
|
GTX22722
|
GeneTex International Corporation
|
NFAT1 [25A10.D6.D2], Mouse Monoclonal Antibody
|
Human, Mouse, Rat
|
FACS, GSA, ICC/IF, IHC-Fr, IHC-P, IP, WB, ChIP assay
|
|
|
GTX23482
|
GeneTex International Corporation
|
NCOR1, Rabbit Polyclonal Antibody
|
Human, Mouse
|
FACS, ICC/IF, IHC, IHC-P, IP, WB, ChIP assay
|
|
|
GTX42261
|
GeneTex International Corporation
|
DC-SIGN [MR-1] (Low endotoxin, azide free), Mouse Monoclonal Antibody
|
Human
|
FACS, ICC/IF, Functional Assay
|
|
|
GTX48427-PRO
|
GeneTex International Corporation
|
Human IL4 protein (active)
|
|
ELISA, WB, Functional Assay
|
|
|
GTX54471
|
GeneTex International Corporation
|
DC-SIGN [DCN47.5], Mouse Monoclonal Antibody
|
Human
|
ICC/IF, Functional Assay
|
|
|
HY-120878-10mg
|
MedChemexpress LLC
|
CXCR2-IN-2 [CAS 1838123-21-9]
|
|
COVID-19-immunoregulation
|
|
|
HY-120878-100mg
|
MedChemexpress LLC
|
CXCR2-IN-2 [CAS 1838123-21-9]
|
|
COVID-19-immunoregulation
|
|
|
HY-120878-25mg
|
MedChemexpress LLC
|
CXCR2-IN-2 [CAS 1838123-21-9]
|
|
COVID-19-immunoregulation
|
|
|
HY-120878-5mg
|
MedChemexpress LLC
|
CXCR2-IN-2 [CAS 1838123-21-9]
|
|
COVID-19-immunoregulation
|
|
|
HY-120878-50mg
|
MedChemexpress LLC
|
CXCR2-IN-2 [CAS 1838123-21-9]
|
|
COVID-19-immunoregulation
|
|
|
HY-120878A-10mg
|
MedChemexpress LLC
|
(R,R)-CXCR2-IN-2 [CAS 1838123-22-0]
|
|
COVID-19-immunoregulation
|
|
|
HY-120878A-100mg
|
MedChemexpress LLC
|
(R,R)-CXCR2-IN-2 [CAS 1838123-22-0]
|
|
COVID-19-immunoregulation
|
|
|
HY-120878A-25mg
|
MedChemexpress LLC
|
(R,R)-CXCR2-IN-2 [CAS 1838123-22-0]
|
|
COVID-19-immunoregulation
|
|
|
HY-120878A-5mg
|
MedChemexpress LLC
|
(R,R)-CXCR2-IN-2 [CAS 1838123-22-0]
|
|
COVID-19-immunoregulation
|
|
|
HY-120878A-50mg
|
MedChemexpress LLC
|
(R,R)-CXCR2-IN-2 [CAS 1838123-22-0]
|
|
COVID-19-immunoregulation
|
|
|
HY-12591-10mg
|
MedChemexpress LLC
|
D-Luciferin (sodium) [CAS 103404-75-7]
|
|
|
|
|
HY-12591-5mg
|
MedChemexpress LLC
|
D-Luciferin (sodium) [CAS 103404-75-7]
|
|
|
|
|
HY-12591A-10mg
|
MedChemexpress LLC
|
D-Luciferin [CAS 2591-17-5]
|
|
|
|
|
HY-12591A-5mg
|
MedChemexpress LLC
|
D-Luciferin [CAS 2591-17-5]
|
|
|
|
|
HY-12591A-50mg
|
MedChemexpress LLC
|
D-Luciferin [CAS 2591-17-5]
|
|
|
|
|
HY-12591B-1g
|
MedChemexpress LLC
|
D-Luciferin (potassium) [CAS 115144-35-9]
|
|
|
|
|
HY-12591B-10mg
|
MedChemexpress LLC
|
D-Luciferin (potassium) [CAS 115144-35-9]
|
|
|
|
